ArticleScientific reports2026

Establishing FDA-approved oncology drugs as GPR176 inhibitor through homology modelling, molecular docking, MMGBSA, DFT, and molecular dynamics simulation.

Felix Oluwasegun Ishabiyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.